Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M1151C2 topical skin safety study in atopic dermatitis
jRCT2031210012Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of difamilast in atopic dermatitis (AD) (2 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Usability of the investigational drug. Started Apr 2021; status: completed.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2031210012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210012.